Literature DB >> 15094226

Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice.

Volker Schmitz1, Lucia Tirado-Ledo, Klaus Tiemann, Esther Raskopf, Thomas Heinicke, Carsten Ziske, Maria A González-Carmona, Christian Rabe, Nicolas Wernert, Jesús Prieto, Cheng Qian, Tilman Sauerbruch, Wolfgang H Caselmann.   

Abstract

BACKGROUND/AIMS: In this study we established an orthotopic tumour model for hepatocellular carcinoma and evaluated a non-invasive high resolution ultrasound technique for diagnosis and follow-up of intrahepatic HCC.
METHODS: Orthotopic liver tumours were induced by intrahepatic tumour cell injection of 10(5) Hepa129 hepatoma cells. Tumour establishment and growth were assessed by explorative laparotomy, ultrasound technique and hepatectomy one and two weeks after tumour cell implantation. Tumour establishment was confirmed histologically in liver sections.
RESULTS: Our results show that the Hepa129 hepatoma cell line is suitable for orthotopic tumour establishment and that tumours can be diagnosed correctly by ultrasound imaging in all cases as confirmed by explorative laparotomy, hepatectomy and cross-sections. Tumour diameters obtained by explorative laparotomy correlated significantly with diameters assessed by ultrasound (r=0.7; P<0.0001). Tumour burden was slightly overestimated (1.2-fold) by ultrasound one week after tumour induction and relative tumour extensions increased 1.7-fold and 1.8-fold within one week as determined by subsequent explorative laparotomy or ultrasound imaging, respectively.
CONCLUSIONS: These data demonstrate in a systematic study that ultrasound imaging can be used as a reliable tool to detect and to follow up orthotopic liver tumours in this tumour model in mice.

Entities:  

Mesh:

Year:  2004        PMID: 15094226     DOI: 10.1016/j.jhep.2004.01.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.

Authors:  Katjana Daskalow; Nadine Rohwer; Esther Raskopf; Evelyne Dupuy; Anja Kühl; Christoph Loddenkemper; Bertram Wiedenmann; Volker Schmitz; Thorsten Cramer
Journal:  J Mol Med (Berl)       Date:  2010-04-12       Impact factor: 4.599

2.  High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice.

Authors:  Itziar Fernández-Domínguez; J Javier Echevarria-Uraga; Nieves Gómez; Zigmund Luka; Conrad Wagner; Shelly C Lu; José M Mato; Maria L Martínez-Chantar; Juan Rodríguez-Cuesta
Journal:  Ultrasound Med Biol       Date:  2011-06-08       Impact factor: 2.998

3.  Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.

Authors:  Peter Dietrich; Laura Wormser; Valerie Fritz; Tatjana Seitz; Monica De Maria; Alexandra Schambony; Andreas E Kremer; Claudia Günther; Timo Itzel; Wolfgang E Thasler; Andreas Teufel; Jonel Trebicka; Arndt Hartmann; Markus F Neurath; Stephan von Hörsten; Anja K Bosserhoff; Claus Hellerbrand
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.

Authors:  Hoi-Hung Chan; Tian-Huei Chu; Hsin-Fan Chien; Cheuk-Kwan Sun; E-Ming Wang; Huay-Ben Pan; Hsiao-Mei Kuo; Tsung-Hui Hu; Kwok-Hung Lai; Jiin-Tsuey Cheng; Ming-Hong Tai
Journal:  BMC Gastroenterol       Date:  2010-07-22       Impact factor: 3.067

Review 5.  Establishment of animal models with orthotopic hepatocellular carcinoma.

Authors:  Tai Kyoung Lee; Kyung Sook Na; Jeonghun Kim; Hwan-Jeong Jeong
Journal:  Nucl Med Mol Imaging       Date:  2014-07-29

6.  Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.

Authors:  Seagal Teitz-Tennenbaum; Qiao Li; Mary A Davis; Kari Wilder-Romans; Janet Hoff; Mu Li; Alfred E Chang
Journal:  J Immunother       Date:  2009 Jul-Aug       Impact factor: 4.456

7.  1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.

Authors:  Miroslaw Kornek; Veronika Lukacs-Kornek; Andreas Limmer; Esther Raskopf; Ursula Becker; Maren Klöckner; Tilman Sauerbruch; Volker Schmitz
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

8.  Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma.

Authors:  Gui-Xing Jiang; Wei Liu; Yun-Fu Cui; Xiang-Yu Zhong; Sheng Tai; Zhi-Dong Wang; Yu-Guang Shi; Chun-Long Li; Shi-Yong Zhao
Journal:  Dig Dis Sci       Date:  2009-12-24       Impact factor: 3.199

9.  Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rγnull mice.

Authors:  Verena Ellerkamp; Sorin Armeanu-Ebinger; Julia Wenz; Steven W Warmann; Juergen Schäfer; Peter Ruck; Joerg Fuchs
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  Creation of a murine orthotopic hepatoma model with intra-abdominal metastasis.

Authors:  Jamie Harris; Andre Kajdacsy-Balla; Bill Chiu
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.